广西奕安泰

Home Page Home Page

Enantiotech Enantiotech

API and Intermediates API and Intermediates

Chiral Technology Chiral Technology

Quality inspection Quality inspection

News Center News Center

Guangxi Enantiotech Pharmaceutical Co., Ltd..

Guangxi Enantiotech Pharmaceutical Co., Ltd., was established on April 29, 2019, is a wholly-owned subsidiary of Enantiocech. It is a manufacturer of advance pharmaceutical intermediates&APIs. It has a standard GMP workshop,an efficient warehouse storage system, and an independent quality system. The main facilities include 5,400-square-meters of quality inspection and R&D building, 30,000 square meters of production workshops, 6,000 square meters of warehouse space, and more than 10,000 square meters of production supporting systems. The company collaborates closely with the world's top international scientific consultant teams, possesses proprietary catalyst technology, with 10 patents authorized.

Guangxi Enantiotech has a total investment of 500 million RMB, covers an area of 107 acres and is built in two phases. Phase I of the project was included in the "Double hundred Double New" project database of the autonomous region in 2019, recognized as a major science and technology special project in Guangxi in 2021, completed and put into operation in December 2021, and became large-scale enterprise enterprise in May 2022. Phase II is set to was started construction in April 2022, with equipment installation scheduled for completion by the end of the year. After the project is fully operational, an the annual output value is approximately 1.5 billion yuan, 20 million yuan in tax revenue, and employ over 300 high-end professionals.

1500 ^cu.m

Total reaction volume

107 ^acres

Guangxi Base Park spans across

23 ^year

clean room workshop operation

广西奕安泰医药科技有限公司

广西奕安泰药业有限公司成立于2019年4月29日，为中山奕安泰全资控股的子公司，是一家生产、销售高端医药中间体、原料药及医药制剂企业。现建有标准的GMP厂房，优良高效的仓库存储系统，独立的质量体系。主要设施有5400平米质检研发楼、3万多平米的生产车间、6千多平米仓库、1万多平米的生产配套系统等。公司与世界顶尖的国际科学顾问团队保持密切的合作关系，并拥有自主知识产权的催化剂专利技术，已授权38项专利。
广西奕安泰药业有限公司总投资5亿元，占地107亩，分两期建设。项目（一期）于2019年列入自治区“双百双新”项目库，2021年获评广西科技重大专项项目，2021年12月竣工投产，2022年5月转为规上企业。项目（二期）于2022年4月开工建设，计划年底竣工投产。项目全部建成投产后，年产值约15亿元，税收2000万元，带动高端人才就业300人以上。